BRCA1 and prostate carcinoma: Notably, ROC curve analysis (Figure 6) demonstrated 100% sensitivity and specificity for BRCA1/2 CNV detection, highlighting the technique’s potential for clinical application in advanced prostate cancer diagnostics.